Table 2 Kaplan – Meier survival analysis of 1-year mortality
| Â | Patients in cohort | Patients with outcome | Median survival (days) | Survival probability at end of time window | ||
|---|---|---|---|---|---|---|
Antifibrotic Group | 166 | 25 | -- | 84.42% | ||
Control Group | 163 | 42 | -- | 69.87% | ||
|  | χ2 | df | p |  |  |  |
Log-Rank Test | 11.556 | 1 | < 0.001 |  |  |  |
|  | Hazard Ratio | 95% CI | χ2 | df | p | |
Hazard Ratio and Proportionality | 0.434 | (0.264, 0.712) | 6.721 | 1 | 0.010 | |